AM ResearchBiofabricationBioprintingMedical ResearchResearch & Education

Researchers propose new volumetric bioprinting solutions for living tissue

Highlighting three recent innovations by UMC Utrecht that will help to make bioprinting more clinically relevant.

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Bioprinting is the printing of living cells and tissues. It’s a promising technique that hopefully, one day, can solve the organ donor shortage by growing organs from patients’ own cells. However, printing living tissues and cells is extremely complicated, and many hurdles need to be overcome to be able to get there. In this article, three recently developed volumetric bioprinting solutions by UMC Utrecht are highlighted that will help to make bioprinting more clinically relevant.

Rise of volumetric bioprinting

The first association with 3D bioprinting is ‘classic’ 3D printing or extrusion printing with plastic filament. This has become popular in the past 15 years or so, as low-cost printers have become widely available. In principle, it should be possible to replace the plastic and print pieces of biologically functional tissue, with different kinds of cells present. But to achieve this, highly detailed and differentiated tissues will have to be made: even a cubic millimeter of organ tissue will need blood capillaries in it as well, so the bar is set very high for printers if we want to create functional tissue that we can implant on a clinically relevant scale.

With the development of bioinks, 3D extrusion bioprinting has become possible. New nozzles, nutritious inks and pre-made scaffolds make it easier for the cells to survive this process. And by using various inks at the same time, different kinds of cells could be deposited and in doing so create tissues. However, layer-by-layer printing still takes a long time; many hours for a multi-cubic centimeter object. Cells are likely to die during this process. Additionally, extrusion prints need to be able to withstand gravity, so the inks need to be sturdy, which means they are not very cell-friendly.

To overcome this slow and gravity-dependent process, volumetric printing has been adopted for bioprinting as well. In this process, a spinning vial with a special gel is exposed to laser light. Where the laser light hits, the photosensitive gel will solidify quickly. This means that with a laser 3D light reconstruction, intricate shapes of multiple centimeters cubed can be created in a matter of seconds. Now, while this solves the issue of speed and gravity, it comes with its own drawbacks. These photosensitive gels can, in this way, only contain cells in suspension, so controlling which kind of cell ends up where – and how many of them – is hard to control. And because the gel is hard, it’s difficult for the cells to move, extend and communicate with each other, which is essential for the formation or even functioning of the tissue.

At the Regenerative Medicine Center Utrecht, researchers are continuously working to overcome these challenges, and the three papers that are discussed below have each solved part of the challenges described above.

Highlighting three recent volumetric bioprinting solutions by UMC Utrecht that will help to make bioprinting more clinically relevant.
Bioprinting: LevatoLab, UMC Utrecht, Reproduced under the terms of the Creative Commons CC-BY 4.0 License (https://creativecommons.org/licenses/by/4.0/).139 Copyright 2019, Published by Wiley-VCH (https://doi.org/10.1101/2023.05.17.541111)

Creating biologically functional regions in a print

Volumetric bioprinting, with which an object a few centimeters in size can be printed in mere seconds, offers many possibilities for the printing of cells. The speed of the process combined with the cell-friendliness of the gel are great advantages. However, when the print is finished, the cells may not be placed exactly where they are needed, nor is it possible to alter the gel much to aid the development, growth or specialization of cells to create functional tissues. Overcoming this hurdle, then, is important, because in our body cells know where to go and where to stay following signals that they sense in specific regions or tissues.

Adding functionality to the printed gel

To make it possible to make chemical changes to the print after the initial printing process, the researchers played with the porosity of the gel, as well as the compounds in it that bind with other molecules in the gel. “With this technique, it is possible to engraft biomolecules to our printed constructs within minutes in a high spatial resolution,” first author Marc Falandt explains. “First we printed our gelatin-based constructs with the volumetric printer, then by infusing these constructs with biomolecules and photoinitiator, we could create complex 3D motives inside the gelatin structures. This method gives us three-dimensional control of the location where you want your biomolecules to be trapped. Something that was not possible before.”

Helping cells find their way by giving them a chemical map

With this innovation, it is now possible to create volumetric prints that can have growth factors or bioactive proteins “painted” into them in any desired 3D shape. For example, signal molecules that guide the direction and formation of blood vessels can be placed in such a way that they create a trail that attracts new vessels only where and when needed inside the 3D printed object.

These signals could then attract the right cells, or help stem cells to fulfill their regenerative potential. Falandt: “This work really takes the first steps into the development and characterization of smart materials that allow biochemical editing in 3D. In combination with the fast volumetric bioprinting technique, this approach is extremely promising for the creation of biofabricated scaffolds that could guide cell behavior and development. It could allow us to closely mimic the complex biochemical environment of native tissues and organs with our 3D bioprints.

Highlighting three recent volumetric bioprinting solutions by UMC Utrecht that will help to make bioprinting more clinically relevant.
Bioprinting (3) en (4): LevatoLab, UMC Utrecht, Reproduced under the terms of the Creative Commons CC-BY 4.0 License (https://creativecommons.org/licenses/by/4.0/).139 Copyright 2019, Published by Wiley-VCH (https://doi.org/10.1002/adma.202300756)

Granular gels for printed cells

For a successfully fabricated tissue, the printed cells need to be pampered in order to survive and thrive in the finished product. And if they are to form a functional tissue, they need to be able to grow, move, and communicate with each other.

Various printing strategies have been tried to solve this, and they all have their pros and cons. In 3D extrusion printing, cells can be deposited in a variety of types and with high numbers, but this process takes very long, causes mechanical stress to the cells and is gravity-dependent – all detrimental to the cells’ survival and functioning. With fast volumetric bioprinting, speed and gravity may have been solved, but here the challenge is that cells are distributed randomly in the resin and in lower numbers, and because the final print consists of solid resin, the cells are unable to function and communicate properly.

Creating a granular microworld

To solve this issue, the materials used for bioprinting must provide an environment that allows for the self-organization and communication of cells. While this is generally possible with soft hydrogels, ensuring high printing resolution and shape fidelity of these materials remains a key bottleneck, especially when using conventional layer-by-layer fabrication techniques.

First author Davide Ribezzi explored the use of granular resins to overcome these challenges. “Granular gels are basically gel microparticles packed tightly together,” Ribezzi said. “While each microparticle possesses comparable properties to its bulk hydrogel counterpart, packed microgel particles can be designed and customized to display a broad array of added useful properties.” Leveraging on particulate biomaterials is therefore a promising strategy to face drawbacks related to bulk cell encapsulation and material processability in the printing processes.

Combining different printing strategies

The granulated resins indeed allowed the researchers to combine extrusion and volumetric printing. Using extrusion printing, certain cells or other chemicals can be specifically deposited in the resin. This approach optimizes the balance between the speed of volumetric printing with the accuracy of extrusion printing. The gel moves around the printing nozzle like custard around an intrusive finger, so the cells can be placed in multiple layers quickly, without having to worry about the strength of the structure. Then, volumetric printing can finish the process by creating and finessing the shapes around the extruded cells.

This process wasn’t without its challenges. Ribezzi: “Processing biological materials always requires lots of attention and meticulous planning of the experiments. But in our research, we exploit the thermal properties of the microgel, which allows for precise tuning of the mechanical and optical properties. This translated into tunable stimuli sensed by the embedded cells. However, this higher degree of tuning needed an even higher degree of attention and precision during the printing process.”

More biological activity

Experiments with cells confirm that the granulated resins allow for much more biological activity after printing, vastly outperforming the solid gels. Within eight days of being printed into the resin, stem cells were able to spread out more, endothelial cells created more junctions and neuron-like cells made more connections to each other.

Ribezzi further commented: “For future studies, we envision the mixing and even local patterning of microgels obtained from different materials. It would allow us to create composite constructs with unique properties, or with bioactive pockets releasing for example drugs. These tools will boost tissue functionality, and open up additional opportunities for tissue engineering, regenerative medicine, and the emerging area of engineered living materials.”

Highlighting three recent volumetric bioprinting solutions by UMC Utrecht that will help to make bioprinting more clinically relevant.
Bioprinting (3) en (4): LevatoLab, UMC Utrecht, Reproduced under the terms of the Creative Commons CC-BY 4.0 License (https://creativecommons.org/licenses/by/4.0/).139 Copyright 2019, Published by Wiley-VCH (https://doi.org/10.1002/adma.202300756)

Bioprinting techniques for functional blood vessels

Volumetric bioprinting is a fast technique, which allows cells to survive the printing process. However, because this type of printing is done in cell-friendly gels, the resulting prints are structurally not very sound. This is a problem for printed blood vessels, which have to be able to withstand high pressures and bending. For this reason, a merger of volumetric bioprinting and melt electrowriting was pursued.

Melt electrowriting is a highly accurate type of 3D printing that works by directing a narrow filament of molten (biodegradable) plastic. It’s able to produce intricate scaffolds that are mechanically strong and able to deal with force. The downside here is that they can’t be printed with cells in there directly, because of the high temperatures involved. Therefore, volumetric bioprinting was used here to solidify cell-laden gels onto the scaffolds.

Merging electrowriting and volumetric printing

The process starts with the creation of a tubular scaffold using melt electrowriting. This is then submerged into a vial with photoactive gel and placed in the volumetric bioprinter. In principle, the laser of the printer can selectively solidify the gel that sits in, on and/or around the scaffold. “In order to get this right, we had to place the scaffold exactly center in the vial,” first author Gabriël Größbacher said. “Any deviation from the center would mean that the volumetric print would be offset. But we managed to center it perfectly by printing the scaffold on a mandril that we fitted to the vial.”

In this study, Größbacher and colleagues tested various thicknesses of the scaffold, which resulted in more or less strong tubes. Finally, they also tested various placements of the bioprinted gels. These could either be placed on the inner side of the scaffold, inside the scaffold itself or on the outside of it. By using two differently labeled stem cells, the team was able to print a proof of principle blood vessel with two layers of stem cells, and seeded epithelial cells in the center to cover the lumen of the vessel.

From tubes to functional vessels

The design could also allow for holes in the side of the print, giving the possibility for controlled permeability of the vessel for the blood to do its function. Finally, the researchers also created more complex structures like forked vessels and even vessels with venous valves that were functional in maintaining a unidirectional flow.

Größbacher: “This was a proof of principle study. What we now need to do is replace the stem cells with functional cells that are part of a real blood vessel. That means adding muscle cells and fibrous tissue around the epithelial cells. Our goal now is to print a functional blood vessel.”

While these innovations provide interesting options to bring bioprinting forward, it will work best if they can be combined and expanded. Group leader Riccardo Levato stated: “Being able to print biologically active molecules into a print that uses granular gel means that the cells can use the molecular information better, as well as grow and develop into a tissue, together with their neighboring cells.”

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based VoxelMatters. Today the company publishes the leading news and insights websites VoxelMatters.com and Replicatore.it, as well as VoxelMatters Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.